Lords Mark Industries Ltd. Secures US FDA Registration, Strengthens Global Healthcare Manufacturing Capabilities

Lords Mark Industries Ltd. has received US FDA registration for its range of surgical consumables, orthopedic supports, and hygiene products. According to the company, this development reinforces its manufacturing standards and supports India’s growing role in global healthcare production.

The company stated that US FDA registration ensures compliance with international norms for product safety, quality, and process integrity. It enables Indian manufacturers to access regulated markets, including the United States, the European Union, and the Middle East.

Also Read: WEF 2025 Davos: Lord’s Mark Industries secures 300 MW solar contract

Lords Mark Industries said the FDA-approved product portfolio includes medical consumables such as cotton crepe bandages, elastic adhesive bandages, cannula fixators, and disinfectant wet wipes, along with orthopedic and rehabilitation products including abdominal and rib belts, lumbar supports, cervical collars, Taylor’s brace, arm slings, shoulder immobilizers, cockup splints, and knee immobilizers. The Lord’s Joy brand portfolio covers baby wipes, bed bath wipes, and refreshing wipes.

Manufacturing and Compliance Framework

The company’s surgical unit, located in Dadra & Nagar Haveli, comprises five integrated divisions and employs over 100 professionals. The facility follows 5S manufacturing principles and maintains an integrated quality control and assurance system with multiple checkpoints for inspection and validation.

The infrastructure includes loom machines, TFO and cheese winders, warping and dyeing units, 38 stitching machines, and an automated elastic adhesive coater. According to the company, the unit operates in line with ISO 13485:2016, WHO-GMP, CDSCO, cGMP, GLP, Indian FDA, and US FDA standards.

Digital Operations and Quality Systems

 

Lords Mark Industries said it has introduced digital tracking and predictive logistics systems across its operations to enhance delivery precision and traceability for both domestic and international markets. The framework uses data analytics for route optimization and packaging traceability to improve turnaround times and reduce costs.

The company also highlighted its six-step Quality Excellence Framework covering specification definition, stage-wise testing, staff training, performance tracking, corrective actions, and continuous improvement.

Management Commentary

 

“Our vision is to make Indian-made healthcare solutions globally competitive in quality and accessible in pricing. The FDA registration supports our goal of expanding into regulated international markets,” said Sachidanand Upadhyay, Managing Director, Lords Mark Industries Ltd.

Manav Teli, Executive Director, added: “The registration reflects our focus on automation, R&D, and consistent quality systems that align with global standards.”

Lords Mark Industries, which operates a subsidiary, Lords Mark Global LLC, in Texas, said it aims to expand its presence in the US and allied markets while scaling manufacturing in India. According to industry data, India has over 700 FDA-registered facilities, underscoring its growing position in global healthcare manufacturing.

With this milestone, Lords Mark Industries Limited — which also operates its subsidiary, Lords Mark Global LLC in Texas — becomes part of a select group of Indian healthcare manufacturers to receive FDA recognition, joining names such as Sun Pharma, Cipla, Dr. Reddy’s, Biocon, Meril Life Sciences, and Poly Medicure. The establishment of its U.S. arm reflects the company’s intent to strengthen its manufacturing base in India while expanding its presence in international markets. India currently has over 700 FDA-registered facilities, highlighting the country’s growing role in global healthcare production.